Tender Details
Ref No 24273782
Document

Tender Notice

Bidding

Not specified

Short Description

Fzš - Chemical Container Wt. Category S - Repeated Entry
Deadline *
Date 02 Mar 2026
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location Czech Republic
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.

Similar Tenders

  • Ref No: 5306291
  • Location: Germany

Open House Drug Discount Agreements Rivaroxaban Film Coated Tablets Except With A Strength Of 2 5 Mg Atc B01Af01

  • Deadline: 05 Apr 2026
  • Ref No: 5304038
  • Location: Germany

Open House Drug Discount Contracts In Accordance With Section 130A Paragraph 8C Sgb V Pemetrexed Atc L01Ba04

  • Deadline: 16 Apr 2026
  • Ref No: 5310172
  • Location: Germany

Open House Drug Discount Contracts In Accordance With Section 130A Paragraph 8C Sgb V Bortezomib Atc L01Xg01

  • Deadline: 16 Apr 2026
  • Ref No: 5396790
  • Location: Germany

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient L

  • Deadline: 27 Apr 2026
  • Ref No: 4642060
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredie

  • Deadline: 28 Feb 2026
  • Ref No: 4646012
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredie

  • Deadline: 28 Feb 2026
  • Ref No: 4644671
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredie

  • Deadline: 28 Feb 2026
  • Ref No: 5975224
  • Location: Germany

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingred

  • Deadline: 30 Apr 2026
  • Ref No: 5227518
  • Location: Germany

Medicines With The Active Ingredient Tiotropium Bromide Atc R03Bb04 Except In The Dosage Form Hard Capsules With Powder For Inhalation

  • Deadline: 31 Mar 2026
  • Ref No: 8267865
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Betamethasone Salicylic Acid

  • Deadline: 10 May 2026
  • Ref No: 8314020
  • Location: Germany

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingred

  • Deadline: 31 Oct 2026
  • Ref No: 4070882
  • Location: Germany

Contract Announcement Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V For Drugs With The Active I

  • Deadline: 10 Feb 2026
  • Ref No: 4071836
  • Location: Germany

Order Announcement Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V For Drugs With The Active Ingr

  • Deadline: 10 Feb 2026
  • Ref No: 4076239
  • Location: Germany

Order Announcement Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V For Drugs With The Active Ingr

  • Deadline: 10 Feb 2026
  • Ref No: 5718312
  • Location: Germany

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Bu

  • Deadline: 30 Apr 2026
WhatsApp Chat